Abstract
One hundred forty consecutive cancer patients had percutaneously placed subclavian vein catheters for up to 882 days' duration. The incidence of suspected and proven catheter-related sepsis was low. This is a cost-effective alternative to tunneled catheter insertion for chronic venous access in cancer patients.
MeSH terms
-
Ambulatory Care / methods*
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use
-
Catheterization / methods*
-
Catheters, Indwelling* / adverse effects
-
Humans
-
Neoplasms / drug therapy
-
Neoplasms / therapy
-
Parenteral Nutrition, Total
-
Patient Care Team
-
Punctures
-
Silicone Elastomers
-
Subclavian Vein
-
Time Factors
Substances
-
Antineoplastic Agents
-
Silicone Elastomers